RSS Subscribe to our Nanotechnology Business News feed

Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company for RNAi Therapeutic Delivery Technologies

Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major pharmaceutical company to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

Apr 13th, 2011

Read more